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Abstract
The oral epithelium, the most abundant structural tissue lining the oral mucosa, is an important line of defense against
infectious microorganisms. HIV infected subjects on highly active antiretroviral therapy (HAART) are susceptible to comorbid
viral, bacterial and fungal infections in the oral cavity. To provide an assessment of the molecular alterations of oral epithelia
potentially associated with susceptibility to comorbid infections in such subjects, we performed various proteomic studies
on over twenty HIV infected and healthy subjects. In a discovery phase two Dimensional Difference Gel Electrophoresis (2-D
DIGE) analyses of human oral gingival epithelial cell (HOEC) lysates were carried out; this identified 61 differentially
expressed proteins between HIV-infected on HAART subjects and healthy controls. Down regulated proteins in HIV-infected
subjects include proteins associated with maintenance of protein folding and pro- and anti-inflammatory responses (e.g.,
heat-shock proteins, Cryab, Calr, IL-1RA, and Galectin-3-binding protein) as well as proteins involved in redox homeostasis
and detoxification (e.g., Gstp1, Prdx1, and Ero1). Up regulated proteins include: protein disulfide isomerases, proteins whose
expression is negatively regulated by Hsp90 (e.g., Ndrg1), and proteins that maintain cellular integrity (e.g., Vimentin). In a
verification phase, proteins identified in the protein profiling experiments and those inferred from Ingenuity Pathway
Analysis were analyzed using Western blotting analysis on separate HOEC lysate samples, confirming many of the discovery
findings. Additionally in HIV-infected patient samples Heat Shock Factor 1 is down regulated, which explains the reduced
heat shock responses, while activation of the MAPK signal transduction cascade is observed. Overall, HAART therapy
provides an incomplete immune recovery of the oral epithelial cells of the oral cavity for HIV-infected subjects, and the toxic
side effects of HAART and/or HIV chronicity silence expression of multiple proteins that in healthy subjects function to
provide robust innate immune responses and combat cellular stress.
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Introduction
Oral lesions occur in a high percentage of HIV infected subjects
on highly active antiretroviral therapy (HAART). These lesions
are initiated at oral mucosal surfaces and are due to opportunistic
co-viral, bacterial, and fungal infections that promote, periodon-
titis, candidiasis, salivary gland disease, apthous ulcers, and oral
warts [1,2]. Although the severity of several HIV-related oral
complications has decreased, while life expectancy has increased
with the advent of HAART, certain oral complications remain
[3,4]. In fact, the incidence of some oral complications including
oral warts, and salivary gland diseases among HIV infected
subjects appears to have increased following the introduction of
HAART, while others such as candidiasis, periodontitis and caries
persist [5,6,7,8]. The fact that some oral sequelae are on the rise,
while others persist in optimally treated HIV infected individuals
poses major problems in patient management.
HAART can profoundly suppress HIV replication and
reconstitutes CD4+ cell counts thus partially preventing HIV-
associated oral opportunistic infections such as candidiasis [9,10].
However, the increases in the occurrence of co-viral initiated
infections such as human papilloma virus (HPV) and its associated
oral warts, epstein-barr virus (EBV) initiated oral hairy leukoplakia
(OHL), and salivary gland diseases with persistent use of HAART
[6,7,11] is troubling and unexpected. There is no evidence to
suggest that these viruses behave differently in HIV-infected
compared to non HIV-infected individuals. However, the lesions
caused by these viral co-infections persist and progress into
malignant phenotypes among HIV-infected individuals [5,12]. In
fact a recent meta-analysis reported an increased risk for infection
related cancers; i.e., HPV, in two immuno-compromised cohorts;
HIV-infected on HAART subjects and renal transplant subjects
[13]. It is therefore possible that the restoration of the immune
system by HAART may be functionally incomplete and, therefore,
its effectiveness in repelling different pathogenic micro-organisms
may vary [14,15,16] or, alternatively, that toxicity associated with
HAART may contribute to oncogenesis. However, this has not
been explored completely [17,18], particularly in the setting of
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limited beneficial effects of HAART towards secondary lesions
might also be due to damage at the molecular level that may have
occurred in the host epithelium during HIV infection and/or
infections prior to initiating HAART, that possibly allows the
comorbid infection to initiate and persist despite CD4-cell count
improvement following initiation of therapy.
HIV and/or HAART mediated changes at the molecular level
in oral epithelium of HIV infected on HAART subjects are poorly
understood and limited to the genome level [5]. Although mRNA
expression analyses have revealed significant changes in host gene
expression, it remains unclear what consequences these changes
bring about at the protein level. Therefore, we pursued the
opportunity to advance our molecular understanding of oral
lesions in HIV-infected on HAART subjects by directly measuring
proteome expression changes in human oral epithelial cells
(HOECs). The present study was undertaken to elucidate the
host proteome response in HOECs from HIV-infected on -
HAART vs. control individuals, thereby providing a detailed
understanding of likely functional changes in cellular processes
that may contribute to comorbid infections. Differential protein
analysis was carried out in a discovery phase using Two
Dimensional Difference Gel Electrophoresis (2-D DIGE) coupled
with mass spectrometry identification, and a subsequent verifica-
tion analysis (using Western blotting) was carried out to identify,
compare and confirm proteins that are changing in HIV-infected
on -HAART subjects vs. HIV-negative individuals.
To leverage the protein abundance changes, identified targets
were used as inputs for bioinformatics analysis of pathways likely
involved in the disease process [19,20]. Thus, we analyzed the
targets identified by the 2-D DIGE experiment using Ingenuity
Pathway Analysis (IPA) to infer potential master regulators of the
processes of interest [21]. IPA analyses provided additional
molecular targets relevant to disease, and some of these
hypothesized targets were also confirmed by Western blotting.
With this integrated approach we have identified a number of
differentially expressed proteins that provide valuable mechanistic
insights into the molecular changes that are precursors for
comorbid oral pathogen infections in HIV-infected on HAART
subjects.
Results
CD4+ cell count and viral load in HIV-infected subjects
A total of 11 HIV-infected male subjects averaging 46.468.7
years of age and 10 healthy donors averaging 22.966.5 years of
age and including both sexes were included in this study. Although
there is a systematic age difference between HIV-infected and
health controls, all subjects are adults ranging from 18 to 58 years
old. Data on the CD4 cell counts and viral load for the HIV-
infected on HAART subjects are shown in Table S1. All HIV-
infected subjects are on HAART except subjects 8 (fully HAART
naı ¨ve) and 11 (3 months off HAART at time of tissue collection).
CD4 cell counts at time of tissue collection compared to nadir
CD4 indicate that there was a overall 4-fold recovery of CD4 after
HAART treatment for HAART treated subjects. Nadir CD4
averaged ,160 indicating that all patients suffered significant
drops in immune function at some point during the course of their
disease. Also, nadir CD4 was very similar for the discovery (mean
,150 cells/mL) and validation groups (mean ,168), showing
consistency between the discovery and validation cohorts. Viral
loads averaged less than 20,000 copies/mL blood for the four
subjects used for discovery proteomics studies. Viral loads
averaged under 3000 copies/ml of blood for the HIV-infected
patient samples used for verification analysis except for the two
HAART naı ¨ve patients who had much higher level of virus, as
expected.
Proteome expression profile and statistical analysis
The initial discovery experiment was designed and performed to
monitor statistically significant changes in proteome expression in
HIV-infected HOECs while minimizing individual patient based
systematic variations by pooling samples from the two separate
patient groups. Although this reduced inter-patient variation it
eliminated the ability to examine patient specific responses. The
average CD4+ cell count per mL of the HIV-infected group for
discovery (subjects 1–4) was 517 while that for validation (subjects
5–10) was 770 (not significantly different), compared to nadir CD4
which averaged less than 170, indicating a significant response to
HAART treatment. Immunological recovery is considered by
many investigators to be above 700 cells/mL and accumulating
evidence suggests levels of CD4+ recovery are dependent on
whether treatment is started before CD4+ counts fall too low [22].
The two lowest CD4+ counts are for the two HAART naı ¨ve
patients, as expected.
The oral (gingival) tissue extracted from subjects, typically
during dental procedures such as molar extractions, is heteroge-
neous, and expansion of cells (without passage) was performed to
promote overgrowth of epithelia. This provided a primary and
homogenous cell population for proteomics analysis. Expansion
also increased the material available for proteomics analysis, as the
gingival tissue from subjects is limited. In the absence of the
expansion step, proteomic results could not be attributed to a
specific tissue type. Thus, HOEC samples consisted of expanded
cells from 4 HIV-infected subjects and from 4 healthy controls
where the cells from each group were pooled after expansion.
Then, the cells from each group were divided into replicates of 4
and an internal standard composed of an equal amount of all
samples was generated as well, such that 4 gels were run with 3
samples (including an internal standard) included in each (Table 1).
Sample size for this study was estimated from power analysis
that was performed using previous 2D-DIGE datasets [20], and
(Yohannes et al, unpublished data). Power curves, (Figure S1),
were generated per hypothesis of the two-sided t-test as a function
of sample size to detect 50% change in protein expression with
Type I error probability a=0.05 or 0.001 using datasets from
technical and biological replicates. It is clear from these curves that
variance (technical and/or biological), significance level, and
sample size have significant effect on power. For pooled samples,
Table 1. Experimental design for 2-D DIGE proteome
profiling.
Gel Cy3 Cy5 Cy2
1 N-1 HIV-1 Pooled sample (N-1 to N4 + HIV-1 to HIV-4)
2 HIV-2 N-2 Pooled sample (N-1 to N4 + HIV-1 to HIV-4)
3 N-3 HIV-3 Pooled sample (N-1 to N4 + HIV-1 to HIV-4)
4 N-4 HIV-4 Pooled sample (N-1 to N4 + HIV-1 to HIV-4)
Biological replicate samples for each group were pooled (HIV1-4; HIV-infected
on HAART, N1-4; healthy controls) and the pool was split into four 50 mgo f
aliquots of technical replicates that were then labeled with Cy3 or Cy5. Each gel
contained the pooled standard (Pooled Std; mix of equal aliquots of each
sample in all experimental groups) and two other subject samples. Thus, the 8
samples were analyzed in triplicate by running four gels. (For detail descriptions
refer ‘‘Materials and Methods section.’’).
doi:10.1371/journal.pone.0027816.t001
Proteomic Signatures in HOECs of HIV+ Subjects
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27816the within variance among replicates arises from technical noise
only. Thus as sample numbers are limiting, the power curve from
the technical replicate at a=0.05 is considered and from this
curve it is clear that using three technical replicates results in
.80% chance of detecting a 50% change. Thus, we designed a
study with pooled samples and four technical replicates (over 90%
power). Accordingly spots with 1.5 and above or 21.5 and below
fold changes and exhibiting statistical significance (T-test P-
value,0.05), were retained as spots of interest in this study. Out of
the total number of spots detected, 1413 were matched in all 12-
gel images (essentially 80% of the total) and the spots deemed
significant were carefully checked for correct matching in every
gel. One hundred fifty three spots, which passed all these criteria,
were considered to be significantly different between the two
experimental groups, and were further investigated.
The subsequent FT-MS/MS analysis on a total of 153 spots of
interest successfully derived sequence data from 131 spots, whereas
the digest for the rest of the 22 spots either did not reveal any
peptides or identified keratin. A total of 20 spots contained
isoforms for 8 proteins due to either post-translational modification
or proteolysis. As the overall expression patterns of the observed
isoforms were similar, duplicates were omitted from the list in
Table S2. Moreover, for 58 spots, more than one protein per spot
passed our stringent filtering criteria and the results for these spots
were also excluded from the list (Table S2) as the average ratio
observed corresponds to the combination of all the proteins
present for a particular spot and individual changes are not
conclusive. Thus we report a total of 61 unique proteins along with
the fold changes that are summarized in Table S2 and detailed
identification information is provided in the Table S3.
A 2D-map of a representative deep purple stained gel is shown
in Figure 1. On this map the pick location of proteins whose
expression is significantly different based on the variance of the
mean change between the groups (P#0.05) are shown. In some
cases, the same protein was identified in different spots across the
2D gel, suggesting the occurrence of post-translational modifica-
tions. The protein abundance changes we report as significant
(Table S2) are for the proteins that have $1.5 or #21.5 changes
Figure 1. The 2D map of deep purple-labeled oral epithelial cellular proteome indicating pick location of a subset of proteins that
changed in response to HIV and/or HAART. Orientation of the pH gradients is indicated on the horizontal axes from 3 pH units (left)t o1 0p H
unit (right), and approximate apparent molecular mass ranges are indicated along the vertical axes 10 kDa (bottom) to 200 kDa (top).
doi:10.1371/journal.pone.0027816.g001
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control subjects. A significant portion of these proteins are down
regulated in HIV-infected subjects compared to the healthy
controls.
Principal component analysis. Global relationships among
samples were visualized by performing a principal component
analysis on the expression data (Figure 2). Before dimensional
reduction, each spot map existed in multi-dimensional space (one
dimension for each of the expression values for a spot). The spot
map comparisons were plotted in two-dimensional space,
corresponding to the first and second principal components of
variation. The first principal component for each spot map is the
weighted linear combination of intensity values that shows
maximum variation, whereas the second principal component is
a weighted linear combination orthogonal to the first component
that has maximum variance. For the spots that are present in more
than 80% of the gels, the 1
st principal component distinguished
84.8% of the variance with 8.6% additional variation distinguished
by the second principal component. This unsupervised principal
component analysis (PCA) demonstrated that the four technical
replicate samples per experimental group generally segregated into
two groups indicating that the variance contributed by the
experiment is smaller than the variance between the two
experimental groups. One would not expect the individual
samples to cluster in a way our experimental groups are
clustered, shown in Figure 2, if the fold changes for the
individual proteins reported in Table S2 arose by chance. In this
way, the PCA further demonstrated the statistical significance of
the fold changes for the proteins reported in Table S2.
Pathways related to protein abundance changes
To understand the relationship of these proteins and the effects
of these changes in the context of their cellular function, to identify
potentially co-regulated partner proteins, and to ascertain their
interactions with other proteins in known networks, the identified
proteins were analyzed using a web-based entry tool developed by
Ingenuity Systems, Inc. (http://www.ingenuity.com). Pathway
analyses revealed that Nrf2 mediated stress response was the
major pathway dysregulated in the comparison of experimental
groups. Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) is a
transcription factor which regulates the expression of many cyto-
protective genes. In addition, lipid antigen presentation (relate to
innate immunity), and acute phase response (related to inflam-
mation) were additional major pathways dysregulated between the
Figure 2. PCA of the proteins mediated by HIV and/or HAART. The protein expression profiles of experimental groups were visualized in two-
dimensional Euclidian space, by using extended data analysis module of DeCyder software as described under ‘‘Materials and Methods.’’ The PCA
distinctly clustered the 8 individual samples into two experimental groups (HIV-infected on HAART and healthy control subjects).
doi:10.1371/journal.pone.0027816.g002
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responses, innate immunity, and inflammation responses are
dysregulated in HIV-infected on HAART HOECs, however these
data lack molecular detail as to the sub-pathways that are
specifically altered, which would provide specific biomarkers or
molecular targets for therapy. To provide a greater degree of
molecular detail, de novo network construction using IPA
produced a sub-network of interactions shown in Figure 3 (with
a P value of ,10
278) that included almost 50% of the total
proteins imported into IPA. The proteins in this network are
annotated primarily with respect to three biological functions
namely, protein folding, post-translational modification, and cell
assembly and organization. On this network, nodes (proteins) with
the red and green highlights are the specific proteins identified in
the current study, while the nodes (proteins) not in color have been
added by IPA to maximize the network connectivity. The red and
the green colors represent the direction of change in protein
expression, with red indicating up-regulated and green indicating
down regulated proteins respectively in HIV-infected subjects as
reported by 2-D DIGE. The edges with the arrowheads described
the direct or indirect (solid or dotted line) nature of the interaction
of these proteins. The solid line without the arrowheads refers to a
known binding interaction based on the IPA database annotations.
Every protein interaction in this network is based on published
research articles. The interactions described by this network
provide a framework for evaluating our targets, and enables us to
identify significant new functional modules that are coordinately
dysregulated. For instance, on the network it is clear that HOEC
responses in these chronically ill HIV-infected subjects include
suppression of protein modules that are essential for stress
responses (such as heat shock proteins). It is also clear that IPA
analysis predicts the involvement and activation of major signal
transduction complexes in controlling the expression changes for
many of the proteins such as the MAPK pathway. As proteins do
not function in isolation, pathway analysis may help uncover the
concerted changes of protein modules in revealing dysregulated
host proteins that may contribute to prediction for secondary co-
viral infections.
Verification by Western blotting. To verify both the
direction and fold changes identified by the 2-D DIGE analysis,
Western blot analysis was carried out for representative proteins
on an independent set of twelve patient samples (six HIV-infected,
Table S1, and six healthy controls) not used in the initial 2-D
DIGE discovery experiments. The oral tissue for these
experiments was also expanded to provide a homogeneous
epithelial cell population (as for the discovery experiments) but
the patient samples were not pooled, thus individual patient
variation was assessed as well. In the first verification study using
three HIV-infected subjects (Table S1, subjects 5–7) and three
healthy controls, we chose to verify key pathway elements; these
included protein disulfide isomerase precursor 1 and 3 (Pdia1,
Pdia3), to measure responses to stress; interleukin 1 receptor
antagonist isoform 1 (Il1nr), to measure inflammatory response;
Cystatin A and B (Csta, Cstb), to measure protease inhibitor
functions; Vimentin (Vim), to measure cytoskeleton integrity;
Serine/threonine-protein phosphatase 2A 65 kDa regulatory
subunit A alpha isoform (Ppp2r1a) to measure effects on
signaling, cell growth and division; and proteasome subunit beta
type-6 (Psmb6), to measure proteasome expression. The relative
fold changes for these proteins were computed using ImageQuant-
TL v2005 software and are summarized in Table 3 with statistical
significance computed using student’s T-test. Overall, our Western
blotting results were in agreement with the directionality of the
abundance changes reported by 2-D DIGE, with the exception of
CstA (Figure 4 and Table 3). This protein exhibited a decrease in
abundance in HIV-infected on HAART subjects as reported by 2-
D DIGE analysis, but the decrease was not statistically significant
with Western blotting (Table 3). Alternatively the results for CstB
were in good agreement between the two approaches. For other
proteins validated by Western blot, Il1rn showed close agreement
by the two methods in terms of direction and fold change, while
the fold changes for Ppp2r1a were lower by Western than 2D
DIGE (21.53 vs. 22.75), and the fold changes were much higher
by Western for Psmb6 (210.3 vs 22.6), although the direction of
change was identical.
In addition, the 2-D DIGE results for Pdia1, for which the spot
was sequenced, were not considered conclusive and this protein
was not reported in Table S2 as the relevant spot also included
Tubb4. A Western blot analysis of Pdia1 identifies statistically
significant four-fold induction of Pdia1 in HIV-infected on
HAART subjects compared to the healthy controls. A major
difference was also observed between HIV-infected on HAART
subjects and healthy controls blots probed for vimentin (Figure 4).
The intensities of the bands for full-length vimentin appeared to be
similar for cell extracts from both HIV-infected on HAART and
healthy control samples. However, very intense lower molecular
weight products appeared in extracts from HOECs of HIV-
infected on HAART subjects. The molecular weight ranges and
the band patterns are similar to the band sizes and patterns
reported for authentic primary and secondary vimentin cleavage
products produced when vimentin is incubated with HIV-protease
[23] or in cells transformed by sarcoma virus [24] and/or when
astrocyte maturation is induced by thyroid hormone [25], or
during oxidized low density lipoprotein induced macrophage
apoptosis [26].
We observed decreases in the heat shock related proteins
Hspb1, Hspd1, Hsp40, Hsp56 and Trap (Hsp90L) in HIV-
infected subjects (Table S2) and pathway analysis suggested
potential involvement of Hsp70 (Figure 3). To determine if the
suppression of heat shock proteins may be mediated through a
common transcriptional factor, we assessed the endogenous level
of Heat shock factor protein 1 (Hsf1) in HOECs from HIV-
infected and healthy controls. In eukaryotes, the key regulatory
molecule in stress response is the heat shock transcriptional factor
(HSF). There are multiple HSF isoforms, with HSF1 being a
major regulator of heat shock protein transcription [27]. As clearly
delineated in Figure 4, multiple isoforms of HSF1 (possibly
unmodified, phosphorylated and/or sumolyated [28]) are observ-
able in the normal subjects, while only the lower molecular weight
form of HSF1 is seen, and only at a low level, in one of the HIV-
infected subjects. The overall intensity reduction for the HIV-
infected on HAART subjects with all bands integrated is 12.5 fold
(p-value 0.04). The suppression of HSF1 in HIV-infected on
HAART subjects compared to the healthy controls suggests that
Table 2. Cellular pathways with greater-than-chance
representation by signature proteins.
Pathways Expectation
NRF2-mediated oxidative Stress Response 8.84E-04
Lipid Antigen Presentation by CD1 2.99E-03
Selenoamino Acid Metabolism 4.0E-03
Acute phase Response Signaling 5.68E-03
Pentose Phosphate Pathway 7.37E-03
doi:10.1371/journal.pone.0027816.t002
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mediated through HSF1 repression. In unstressed cells, HSF1
exists as inactive monomer forming complexes with a variety of
different multimeric proteins, many of which contain either
HSP40/HSP70 or HSP90 [29,30]. In response to stress or other
stimuli the inactive HSF1 undergoes trimerization, and hyperpho-
sphorylation, followed by nuclear localization and activation to
elicit transcriptional activation of heat shock proteins [27].
Although HSF1 is essential to attenuate stress in chronic disease,
our analysis of total HOEC lysates verifies significant losses of
HSF1, reducing the cells’ ability to respond to stress. The reduced
levels of HSF1 may have influences beyond the heat shock/stress
response of HOEC cells as HSF1 has many other non-stress
targets of transcriptional activation, including cytokines and
chemokines [31] highlighting the dysregulation of inflammatory
pathways in the cells from HIV-infected on HAART subjects.
Verification for Mitogen-Activated Protein Kinase
pathway
IPA predicted involvement of major signal transduction mole-
cules that act as potential master regulators. To validate this
prediction (Figure 3), we assessed the endogenous level of phospho-
c-Jun N-terminal kinases (phospho-JNK), as it directly interacts with
glutathione-S transferase 1 (GSTP1), one of our significantly down
regulated targets, and phospho-MEK1/2 (MAP kinase kinase, the
upstream activator of ERK) via Western blot on HOEC lysates
from four HIV-infected patients; two on HAART (patients 9, 10;
Table S1) and two HAART naı ¨ve (patients 8, 11; Table S1) and
three healthy controls. Figure 5 and Table 4 show that HOEC
lysates from HIV-infected subjects have 3.1-fold more phospho-
MEK1/2 than those of the healthy controls (p-value 0.009) while
total MEK is reduced (1.4-fold) but the change is not significant.
Phospho-JNK is seen to be higher in HIV-infected patients but the
change is not statistically significant while total JNK is unchanged.
The ratios of p-MEK/MEK and pJNK/JNK were also examined;
p-MEK/MEK increases five-fold in HIV infected patients (p value
0.05, data not shown) while the change in the ratio of p-JNK/JNK
is not significant. The data from the HAART naı ¨ve patients 8 and
11 (HIV+, lane 1, 4) are not significantly different from the patients
on HAART (data not shown). The p-JNK level is quite variable in
the HIV-infected and control lysates and is likely influenced by
other factors than purely HIV-infection.
Figure 3. Protein networks associated with the proteins differentially expressed in response to HIV and/or HAART. The network was
generated by Ingenuity pathway analysis (IPA) software using the list of differentially expressed proteins identified by 2-D DIGE/MS analysis.
Individual proteins are represented as nodes, and the different shapes of the nodes represent the functional class of the proteins. The edges define the
relationships of the nodes: the arrowheads indicate the direction of the interaction.
doi:10.1371/journal.pone.0027816.g003
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samples compared to controls and has been shown to bind and
inhibit the activity of JNK [32,33]. Activation of JNK would be
consistent with suppression of GSTP1 in HIV-infected on
HAART subjects. Usually, JNK activation is accompanied by
ERK deactivation or vice versa. It has been well established that
JNK plays a pro-apoptotic function in response to various cellular
stress, whereas ERK is primarily involved in proliferative response
[34,35]. However, a recent study by Kins et al demonstrated a
parallel activation of both JNK and ERK through PP2A inhibition
[36]. From both 2-D DIGE and verification Western analysis on
Ppp2r1a, we detected statistically significant suppression of
Ppp2r1a, a regulatory sub unit of PP2A, in HIV-infected on
HAART subjects compared to healthy controls. Thus, similar to
the reports of Kins et al, phospho-MEK1/2 in diseased subjects
suggests that activation of MEK1/2 could be mediated through
suppression of Ppp2r1a.
Discussion
HAART ameliorates several pathological features of HIV in
human oral epithelial mucosa such as candidiasis. However, the
prevalence of multiple comorbid related infections related to HIV
do not necessarily appear to decrease concomitantly with
HAART. An examination of molecular changes in oral tissue
upon HIV infection and in the context of HAART is necessary to
understand these comorbidities. In this study we have focused on
proteomic expression changes in oral epithelia, to understand the
possible mechanisms and/or host responses that are responsible
for comorbid infections and we have identified changes in
expression for multiple proteins of HIV-infected subjects com-
pared to HIV- control individuals. Interestingly, many of these
proteins have been shown to interact with HIV proteins and/or
whose expression is HIV related [37,38].
Table 3. Relative fold changes for selected proteins that were
identified either by 2-D DIGE/MS and/or by network analysis
as determined by verification immunoblot analysis.
Protein HIV-infected/normal
a p-value (t-test)
Ppp2r1a 21.53 0.0061
Pdia3 4.30 0.0013
Pdia1 4.46 0.0073
Psmb6 210.3 0.0003
Il1rn 22.30 0.0393
Vim (upper band) 3.28 0.0238
Vim (lower band) 6.93 0.0065
CstA 1.31 0.156
CstB 21.36 0.031
HSF1 212.5 0.0425
The mean values of the fold change and the t-test are based on the
independent measurements from Figure 4.
aThe fold changes is expressed as a ratio between the mean intensity of
immunoblot for the HIV-infected on HAART and healthy controls after
normalization to beta-actin.
doi:10.1371/journal.pone.0027816.t003
Figure 4. Protein abundance for representative proteins assayed by immunoblotting. Twenty micrograms of HIV-negative healthy control
and HIV-infected on HAART subjects protein extracts was loaded per lane, each lane representing one of the three replicates per experimental group.
The resulting blots were probed with antibodies that are specific to:- Ppp2ra1, PDIA3, PDIA1, Vim, PSMb6, IL1RN, CSTA, CSTB, and HSF1, as well as b-
actin as a loading control. Relative -fold changes for these proteins in HIV-infected on HAART subjects compared to the healthy controls are given in
Table 3. N1_3, healthy controls; H1_3, HIV-infected on HAART subjects (Table S1, subjects 5–7).
doi:10.1371/journal.pone.0027816.g004
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It is evident that a significant portion of the proteins we report
in this study (Table 2), are down regulated in HIV-infected
compared to HIV- control subjects. The molecular drivers of this
down-regulation are of interest. The direct presence of virus in
oral epithelial cells is debatable and has been addressed in only a
few in vitro studies [39,40,41]. Although HIV is most likely not
epitheliotropic, host infection with virus affects epithelial homeo-
stasis and function in a number of ways. The epithelium is
continually exposed to a number of oral pathogens and related
stimuli. These stimuli include HIV-infected CD4
+ T cells,
monocytes, and macrophages, lymphocytes, and dendritic cells
that come in contact with the epithelium. Upon host cell lysis,
actively secreted HIV and HIV-induced pro-inflammatory
cytokines are released. This state of chronic immune activation
may mediate some or all of the changes in protein expression we
see in these studies and may drive susceptibility to comorbid
infections [42,43].
At present we have no unbiased discovery proteomics data
available from HOECs of HAART naive HIV-infected subjects. It
is possible some of the down-regulation themes are due to the
antiviral therapy [44,45]. Thus, although the precise source of the
dysregulation cannot be entirely established at this time, protein
expression changes in separate HIV-infected on HAART HOEC
subject samples were consistently observed. Moreover, we were
able to show that for MAP kinase-kinase phosphorylation, the
effects of HAART do not appear to be significant. Many of the
down-regulated proteins have been linked to pro- and anti-
inflammatory responses and oxidative stresses [46,47]. The list
includes, but is not limited to, proteins that are involved in protein
folding and trafficking as well as in both pro- and anti-
inflammatory responses (e.g., Hspb1, Dnajc7 (Hsp40), Fkbp4
(Hsp56), Hspd1 (Hsp60), Trap1 (Hsp90L), Calr, and Cryab2),
proteins that are involved in redox homeostasis (e.g., Gstp1,
Prdx1, and Ero1), and proteins that are involved in limiting the
inflammatory responses (e.g.; IL-1RA, Galectin-3-binding protein,
annexin III, and VI). Thus, the ability of oral epithelial cells of
HIV-infected on HAART subjects to respond to stress is
significantly attenuated compared to HIV- control subjects.
Heat shock proteins (Hsps) play an essential role as molecular
chaperones by assisting the correct folding, assembly, and
transport of proteins, as well as mediating degradation of
polypeptides that are damaged due to various types of stress.
Figure 5. Endogenous levels of MEK1/2, JNK1/2, p-MEK1/2, and p-JNK, predicted to be activated by IPA, assayed by
immunoblotting. The blots were probed with antibodies specific to MEK1/2 and JNK and phosphospecific antibodies to their phosphorylated
counterparts in the total lysates indicated from left: Healthy controls (1–3); HIV+ (1–4), HIV-infected subjects, with subjects in HIV+ lanes 1 and 4
HAART naı ¨ve while 2 and 3 are on HAART (see also Table S1, subjects 8–11).
doi:10.1371/journal.pone.0027816.g005
Table 4. Relative fold changes assayed by Western blotting
for representative proteins that were predicted to be
activated by network analysis.
Protein HIV-infected/normal
a p-value (t-test)
p-MEK1/2 3.13 0.0090
MEK 21.37 0.3523
P-JNK-54 1.80 0.3446
P-JNK-46 1.24 0.7387
JNK-54 21.03 0.6401
JNK-46 21.09 0.4672
The mean values of the fold change and the t-test are based on the
independent measurements from Figure 5.
aThe fold changes is expressed as a ratio between the mean intensity of
immunoblot for the HIV-infected on HAART and healthy controls after
normalization to beta actin.
doi:10.1371/journal.pone.0027816.t004
Proteomic Signatures in HOECs of HIV+ Subjects
PLoS ONE | www.plosone.org 8 November 2011 | Volume 6 | Issue 11 | e27816Depending on the nature of the Hsp itself, the source of the
accompanying stress related antigen, the local concentration of the
Hsp, the nature and concentrations of other Hsps and the
microenvironment in which the Hsp is encountered, these proteins
can mediate both pro- and anti-inflammatory immune responses
[46], suggesting that these molecules play a key role in the
maintenance of immunological homeostasis. Heat shock proteins
exhibit pro-inflammatory functions when they are expressed and
released from cells where damage occurs and are exported either
to the cell surface or to extra-cellular body fluids including blood
[47]. Under normal physiological conditions, Hsps induce pro-
inflammatory adaptive immune responses. A current report by
Kebba et al, has shown significantly higher surface expression of
heat-shock protein receptor CD91 on monocytes of HIV infected,
long-term non progressors, suggesting that HIV antigen uptake
and cross-presentation mediated by CD91 may contribute to host
anti-HIV defenses and play a role in protection against HIV
infection [48]. The concurrent suppression of a number of heat
shock proteins, heat shock factor protein 1(HSF1), and known
anti-inflammatory responses of the immune system, such as
interleukin 1 receptor antagonist, and galectin-3-binding protein
in oral epithelium of HIV chronically infected subjects, suggest
that a sustained presence of HIV infection eventually leads the
immune system into a state of immunological tolerance towards
multiple antigens. A similar pattern of protein expression change is
found in HIV-infected on -HAART subject samples used for
verification experiments. This result supports the notion that
HAART only provides partial immune recovery, especially to the
peripheral but not to the local immune system, in HIV-infected
individuals. The observed suppression of these immune modula-
tors could also be caused by prolonged usage of HAART. In this
regard, it will be interesting to examine the expression status of
heat shock proteins in HAART naive HIV-infected subjects.
Furthermore, our results also point to the crucial role for local, oral
mucosa-specific, innate-immune functions in controlling comorbid
infections.
Suppression of proteins that are involved in limiting inflamma-
tion, adds to the theme of chronic inflammation and immune
activation. For example, decreased calreticulin precursor (Calr)
and annexin III and IV play into pro-inflammation, as less Calr
mediates less nuclear export of nuclear receptor subfamily 3, group
C, member 1 (NR3C1); an important receptor that glucocorticoids
bind to, in order to dampen inflammation [49]. Moreover,
suppression of annexin III and IV, further support this theme, as
annexins suppress phospholipase A2 which suppresses arachidonic
acid release, resulting in less prostaglandin and leukotriene
expression [50,51]. Therefore, less annexin means more prosta-
glandin and leukotriene expression leading to increased inflam-
mation. Overall, we see multiple examples of protein abundance
changes consistent with a higher baseline inflammation level in
HIV-infected on HAART HOECs than in controls.
In addition to heat shock proteins and anti-inflammatory
proteins being suppressed in the HIV-infected subjects’ oral
epithelium, proteins associated with oxidative stress such as Gstp1,
Prdx1, and Ero1 are also down regulated. The first two are
antioxidant enzymes; i.e., they prevent the buildup of reactive
oxygen species (ROS). Interestingly, it was recently reported that
individuals on HAART have increased levels of ROS, such as
glutathione peroxidase (Gpx), in their circulation, with concom-
itant decreased levels of antioxidants such as glutathione
reductase, over time [52]; a clinical finding that supports our
conclusions. Reduced levels of antioxidant enzymes and/or
oxidative stress, in general, are known to up-regulate inflammatory
cytokine activities in individuals receiving HAART [53]. The
observed suppression of oxidoreductase enzymes known to be
induced by hypoxia, such as Erol1 [54,55], as we report herein,
suggests an increased presence of ROS in oral epithelium, which is
consistent with a significant increase in ROS in the circulation of
HIV infected individuals on HAART. It is generally accepted that
ROS are a source of oxidative stress that can adversely affect the
immune response and activate certain latent viruses [56,57],
thereby predisposing the epithelium to secondary infections.
GSTP1, in addition to being associated with phase II
detoxification of the products of oxidative stress, has recently
been implicated in the regulation of cell proliferation and
apoptosis through direct interaction of c-Jun N-terminal kinase,
(JNK) [32,58]. Furthermore, MAPK and upstream MAPK kinase
dephosphorylation has been attributed to PP2A [36,59,60], in
addition to a unique family of dual specific MAP kinase
phosphatases [35]. In agreement with these reports, the suppres-
sion of Ppp2r1a in HIV-infected subjects may regulate the
catalytic activity of PP2Ac, which in turn may contribute to the
activation of not only JNK but also MEK1/2, a kinase for ERK.
Although such a mechanism is consistent with the data, it
represents only one plausible mechanism linking the possible
pathways that are common for the activation of both JNK and
ERK.
Protein up regulation themes
The proteins that are up regulated in HIV-infected subjects
include proteins that are involved in redox homeostasis such as
protein disulfide-isomerase A1 precursor (Pdia1), and protein
disulfide-isomerase A3 precursor (Pdia3). Although endoplasmic
reticulum-resident proteins, protein disulfide isomerases (PDIs) are
commonly detected at cell surfaces, and changes in the expression
of intracellular PDIs are reflected in the their expression on cell
surfaces [61]. These increases in Pdia1 and Pdia3, with a
corresponding decrease in ER oxidoreductin (Ero1l alpha) are
consistent with antioxidant imbalances associated with HIV-
infection and a potential prolonged usage of HAART [52]. The
decrease in the level of Ero1l alpha in HIV-infected subjects is
probably attributed to the increases in the ROS in the ER. The
Ero1l alpha enzyme is a flavoprotein that can couple the
introduction of disulphide into the PDI with the reduction of
oxygen to liberate hydrogen peroxide. For every disulphide
introduction into PDI, one molecule of hydrogen peroxide can
theoretically be produced. The production of this source of
reactive oxygen species leads to ER-generated oxidative stress. On
the other hand, PDIs have a direct role in the antioxidant system
and mainly participate in regenerating peroxiredoxins that are
oxidized by peroxides [62]. Thus, the induction of both Pdia1 and
Pdia3 in HIV-infected on HAART subjects could have a
protective role by avoiding the deleterious accumulation of ROS
in the ER, and maintaining a physiological balance between the
redox systems. Therefore, the increase in the expression of PDIs
and a concomitant decrease in the expression of Erol is consistent
with a protective response to the oxidative stress associated with
the down-regulated families of antioxidant enzymes that play an
important role in redox regulation and detoxification in these cells.
Another notable finding is accumulation of vimentin degrada-
tion products in HOECs of HIV-infected individuals. Western blot
analysis of this protein (Figure 4), identified both quantitative and
qualitative changes for vimentin in HIV-infected subjects, in
particular the appearance of vimentin degradation bands. Muller
et al reported major cleavage products (spanning from 46–57 Kda
and 29, and 26 Kda) of vimentin during oxidized low density
lipoprotein induced macrophage apoptosis [26]. Since HAART
has been associated with increased levels of LDL and ROS in
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regulation of a group of proteins that decrease apoptosis induced
by ROS; i.e., Prx1, Gstp1, Cryab Hspd1, Hpb1, Lgals3bp, Ox-
LDL mediated apoptosis of HOECs, may lead to vimentin
fragmentation. Of note, HIV protease fragments vimentin both in
vivo [63] and in vitro [23], and the number and size of vimentin
fragments reported are also very similar to our Western blot
results. While HIV may not infect epithelial cells efficiently (e.g.
abortive infection may be a feature of the disease related effects),
we cannot entirely rule out that HIV protease is present in the
local epithelial environment during HIV permissive cell lysis.
Although our study identifies multiple pathways and proteins
dysregulated in HIV-infected on -HAART subjects, some caveats
must be admitted as this research is still in its early stages. First, the
study only comprises a total of twenty-one subjects, with only eight
individuals in the discovery phase. In addition, there is a
systematic difference in the average age of the HIV-infected and
control groups, as age-matched HIV negative volunteers under-
going the same surgical procedures were quite difficult to enroll.
Thus, it is entirely possible that this sub-group of subjects may not
broadly reflect the molecular alterations of a larger patient
population and that important HIV related pathways may have
easily been overlooked. Also, some of the differences may be
attributable to age differences alone. However, the subjects are all
adults from 18–58 years, which is an age range unlikely to be
biased by senescence.
Despite the potential limited discovery set, the verification
experiments, which were conducted on individual (un-pooled)
patient samples, entirely confirmed the pathways and proteins
identified in the initial discovery phase. While intact oral mucosa is
composed of multiple cell types; these experiments utilized a
homogeneous epithelial cell population, in order to provide results
that could be unambiguously attributed to this cell type. Thus,
additional studies, either by Western or preferably by immuno-
histochemistry, performed on primary oral tissue, will be of
interest to fully understand the protein dysregulation of the oral
mucosa associated with HIV-infection on HAART. Furthermore,
additional studies on HIV-infected, HAART naive subjects are
needed to dissect the effects of HIV from those of HAART as we
have on-HAART vs HAART naı ¨ve data only for MAP kinase
kinase phosphorylation and for only two patients in each of these
groups. Lastly, these studies suggest the potential for epigenetic
variation, if not silencing in the oral epithelia, mediated by HIV or
HAART related chronic effects. This is related to the interesting
phenomena that despite the primary cellular expansion of the oral
epithelial cells, the resultant cell populations represented by the
HIV-infected vs. non infected groups have considerable variation
in proteome expression. Silencing of oral cells in DNA damage
and cancer is a theme of increasing interest, as is epigenetic
silencing in general [64,65], and future experiments to examine
histone modifications or promoter methylation changes are
certainly of interest to further explore the molecular basis of these
differences.
In summary, our study has identified over 60 candidate proteins
whose expression is dysregulated in HOECs of HIV-infected on
HAART subjects and changes in the expression levels of these
proteins could negatively impact local epithelial immunity. These
proteins represent potential biomarkers for diagnostic and
prognostic purposes and the dysregulated pathways are potential
targets for novel therapies to combat co-infection risks. In
addition, these biomarker proteins may be detectible in saliva,
which is likely to contain significant quantities of oral tissue related
proteins. Salivary biomarkers may reflect changes in oral
pathology related to these findings and may represent an accessible
oral fluid suitable for more routine diagnostic analysis.
Overall, the data suggests that local immune dysregulation in
HIV-infected individuals involves down regulation of proteins
which are necessary to attenuate cellular stress, to induce pro-and
anti-inflammatory responses, and proteins which regulate ROS.
The down regulation of these important clusters of proteins and
pathways identified in this study may represent global epithelial
defects that may contribute to increased susceptibility to infection
observed in chronically ill HIV-infected subjects. While evaluation
of the proteome expression in the two experimental groups does not
distinguish protein expression patterns that may be due to HAART
from those that are associated with chronic HIV infection, it does
provide leads to establish association between the observed protein
changes and epithelium susceptibility towards comorbid infections.
Materials and Methods
Reagents
The majority of chemicals in this study were obtained from GE
Healthcare (Piscataway, NJ), Thermo scientific (Rockford, IL), and
Invitrogen (Carlsbad, California) and used without further
purification unless otherwise stated. Antibodies to Ppp2r1a,
Psmb6, and b-actin, loading control (Abcam, Cambridge, MA)
and antibodies to Pdia1, Pdia3, Vim, Il1ra, HSF1, CstA, and CstB
(Sigma Aldrich, St. Louis, MO), MEK1/2, Phospho-MEK1/2,
JNK, Phospho-JNK (Cell Signaling Technology, Danvers, MA)
were purchased from the indicated vendors.
Ethics Statement
Volunteers have been used as the source of material for the
described work outlined in this manuscript. Human gingival tissue
overlying impacted third molars from HIV-infected and healthy
control subjects were collected after written informed consent was
provided by study participants and/or their legal guardians.
University Hospital Case Medical Center Institutional Review
Board (IRB) Protocol #: 19981017 approved this study.
Clinical Samples
Human gingival tissue overlying impacted third molars were
obtained from HIV-infected subjects (48.068.7 years) and healthy
controls (22.966.5 years). Both pretreatment CD4 T-cells data
(nadir CD4) and CD4 T-cells after HAART at the closest date to
tissue collection, as well as viral load per ml of blood from the
HIV-infected subjects were determined (Table S1). Also, no
diagnosis of gingivitis; i.e., inflammation of the gingival tissue, or
periodontitis; i.e., alveolar bone loss, was observed in the biopsy
sites from healthy or HIV-infected subjects.
Human Oral Epithelial Cell (HOEC) preparation
Primary human oral epithelial cells (HOECs) were isolated and
expanded in serum free keratinocyte growth medium with
supplements as previously described by Krisanaprakornkit et al
[66,67]. Briefly, the epithelial layer was separated from the
underlying fibrous connective tissue with dispase. A single cell
suspension was prepared from the epithelial sheets by trypsiniza-
tion and repeated pipetting. Cells were suspended in serum-free
EpiLife media (Cascade Biologics Inc, Portland, OR), and plated
on 10 cm petri dishes and grown to near-confluence. After
reaching .80% confluence, cells were detached from the petri
dish, pelleted, frozen and stored in liquid nitrogen until used for
expression proteomics and verification analyses. Samples for the
original 2-D DIGE analyses were pooled HOECs from 4 HIV-
infected (Table S1, subjects 1–4) and 4 HIV- negative individuals
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separate HOECs from HIV-infected (Table S1, subjects 5–11)
and healthy control subjects.
Sample size and Power analysis
To estimate sample size for this study power analysis was
performed using two datasets from previous 2D-DIGE experi-
ments [20], and (Yohannes et al, unpublished data). One of the
datasets is from technical replicate gel images that were run using
the same sample but labeled with either Cy3, or Cy5. The second
dataset is from biological replicate gel images. Standardized
volume of protein spots were exported into excel using XML
Toolbox within DeCyder software. Once spots that are present
across all the gel images were filtered, the within group variance
for each spot followed by upper quartile variances were computed
on a log transformed spot standardized volumes. Power for
different sample size at 0.05 or 0.001 significant level, and using
upper quartile variance and 50% change in expression was
computed via Power and Sample Size Calculator Version 3.0.43 (a
free package: http//biostat.mc.vanderbilt.edu/twiki/bin/view/
main/PowerSampleSize). The relationship between power and
sample size was plotted in Microsoft Excel.
Protein extraction and fluorescence dye labeling
Sample preparation was conducted as previously described [20].
Briefly, total protein was harvested from the respective HOEC
samples. Protein clean up and concentration of each sample was
determined using a 2D cleanup and quant kits (GE Healthcare),
respectively. For 2D DIGE experiments, four biological replicates
from control and four from HIV-infected subjects were pooled in
order to minimize interpersonal variation as well as meet the
minimum total protein sample size required to carry out the
experiment. The samples were then split into four 50 mg aliquots.
An additional sample, a pool of 100 mg protein from each group
was collected from HIV-infected and normal samples (200 mg
total) and split into four 50 mg aliquots and used as an internal
standard. Thus, samples from either HIV-infected or healthy
control were labeled with Cy3 or Cy5 cyanine dyes alternatively
while the internal standard samples were labeled with Cy2 dye by
the addition of 400 pmol of Cy dye in 1 mL of anhydrous N,N
dimethylformamide per 50 mg of protein. A dye-swapping scheme,
as shown in Table 1 was used such that the four samples for any
condition were variously labeled with Cy3 or Cy5 to control for
any dye-specific labeling artifacts. Labeling was performed for
30 min on ice in the dark; the reaction was then quenched with
10 mM lysine and additionally incubated for 10 min.
Gel electrophoresis
The quenched Cy3 and Cy5-labeled samples, to be partitioned in
the same gel according to the experimental design in Table 1, were
then combined and mixed with an aliquot of Cy2-labeled internal
standard and an equal volume of 26sample buffer (8 M urea, 4%
w/v CHAPS, 2% w/v dithiothreitol (DTT), 2% v/v Pharmalytes 3–
10 NL) was added. Prior to isoelectric focusing (IEF), an additional
350 mg of unlabeled protein was added (for later spot picking and
protein identification) and the mixtures were brought up to 450 ml
with 16 rehydration buffer. The mixed samples were then
partitioned according to their isoelectric point (pI) and molecular
weight, in two dimensional gels, as previously described [20].
Image acquisition and spot quantification
Gel images, acquisition and spot quantification were carried out
as previously described [20]. Briefly, data analysis was carried out
using a total of 12 gel images consisting of four replicate images
from healthy control, four replicates of HIV-infected and four
from the internal standards, which were pooled mixtures of equal
aliquots of each experimental sample. The pick gel image was also
processed with the rest of the gel images but not included in the
analysis. In order to compare protein spots across the eight gel
images, image analyses were conducted in two steps using
DeCyder v6.5 2D differential analysis software (GE Healthcare).
In the first step, the set of three images from a single gel were
loaded into differential in-gel analysis (DIA) module within the
DeCyder software to detect and quantify intra-gel spots. For the
subsequent inter- gel differential analysis, the DIA workspaces for
all the gels were saved and loaded into the biological variation
analysis (BVA). In the BVA module, the image with the largest
number of protein spots was assigned as the master image. Sample
(Cy3 or Cy5 labeled) spot maps were assigned into healthy control,
HIV-infected and all internal standard and the pick spot maps
were assigned into standard and pick folders, respectively, in the
experimental design view of the BVA modules. Once the spots
from the common standards were matched across the analytical
gel images and with the pick gel image, the standardized volume
ratio for each standard image from the different gels was set to the
value 1.0 in order to compare ratios between matched protein
spots in the different gels (groups). Thus, the ratios of the log
standardized protein spot abundances (differences in expression)
between the groups were computed.
To test for significant differences in expression of proteins
between the two experimental groups, T-test was performed at a
significance level of 0.05; thus, for every hundred spots tested, five
false positives would be expected. Specifically, the data were
filtered using the average volume ratios of 1.5 and above or 21.5
and below fold differences in expression and with false discovery
rate adjusted (FDR) T-test p value of 0.05 or less and assigned as a
spot of interest. For the spots that displayed significant differences
in expression between the groups, a pick list with pick location and
coordinates were generated. The pick list along with the post-
stained pick gel was transferred to the automated Ettan spot picker
and excised gel plugs were placed into a 96-well plate for the
subsequent in-gel digestion and mass spectrometry analysis of the
peptide for protein identification.
Multivariate analyses were performed on the expression data
derived from the BVA using the DeCyder extended data analysis
(EDA) software. The gel images were grouped such that the 4-
technical replicates for each experimental condition formed a
group. Once the BVA was imported into EDA, the data was
filtered so that only 153 spot features exhibiting statistically
significant (T-test p,0.05) changes and present in more than 80%
of the spot maps were considered. The global relationships among
spot maps were visualized by performing a principal component
analysis (PCA) on these spot features.
In gel digestion and protein identification
The proteins in the gel plugs were digested with trypsin
(Promega) using a modified protocol adapted from Shevchenko
et al. [68]. Tryptic digests were extracted from the gel matrix,
concentrated by SpeedVac avoiding complete drying, and
reconstituted in 0.1% formic acid. The protein digests were then
trapped onto a pre-column (C18, PepMap100, 300 mm 65 mm,
5 mm particle size, 100 A ˚, Dionex) and desalted on-line in mobile
phase A (0.1% formic acid in 5% acetonitrile) at 10 mL/minute for
10 minutes using a Dionex Ultimate 3000 capillary LC system on
line with an LTQ- Fourier Transform (FT) mass spectrometer
(Thermo Electron Corp., Bremen, Germany). Each sample was
subsequently loaded onto a Dionex C18 PepMap 75 mm615 cm
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in 85% acetonitrile). Separation of peptides was obtained with a
linear gradient of 2% per min, starting with 100% of mobile phase
A. Subsequently, the peptides were infused at a flow rate of
300 nL/min via PicoTip emitter (New Objective Inc., Woburn,
MA) a voltage of 1.8 kV into LTQ-FT mass spectrometer to
acquire mass spectrum data (alternating full MS scan and MS/MS
scans). Survey data was acquired from m/z of 400 to 1600 and the
precursors were interrogated by MS/MS per switch. The switch
into MS/MS was based on precursor intensity and 5 scans were
acquired for every precursor interrogated.
The tandem mass spectra were annotated and peak list files
were generated, commonly referred to as. DTA files, by running
SEQUEST extract_msn algorithm in Bioworks version 3.2
(Thermo Electron, Bremen, Germany). The mass range m/z
400–3500 from full scan data, with an absolute threshold of 100, a
minimum ion count of 12 and a precursor ion tolerance of 1.4 Da
were used to generate the .DTA file. Prior to searching, non-
redundant databases of 3,893,302 sequences (release 07/04/06)
were downloaded in FASTA format via file transfer protocol (FTP)
from the website of the NCBInr. These databases were stored
locally and a subset human database was created and indexed to
produce faster search times. The resulting peak list (.DTA) files
were then used to interrogate sequences present in an indexed
human subset database (137,607 sequences stored locally) by
running SEQUEST SEARCH algorithm of Bioworks software
version 3.2. SEQUEST searches were performed with maximum
peptide and fragment ion mass tolerance of 2.5 and 1.0 Da
respectively, with partial methionine oxidation, and complete
carbamidomethylation of cysteine. Two missed cleavage sites were
also allowed in the search parameters. The criteria for each
protein identification was a minimum of two peptides with a
significant peptide expectation (P,0.001), peptide Xcorr 1.9, 2.7,
and 3.5 for the charge states and +1, +2, and +3 respectively, and a
minimum Delta CN (Delta correlation) of 0.1. The correlation of
theoretical molecular weight and pI with the gel region were also
generally considered. In addition all the MS/MS spectra identified
by SEQUEST were manually verified for spectral quality and
matching y and b ion series (A complete protein list and
annotation criteria are included in the Table S3).
Network Analysis
The data set with a list of regulated proteins identified by 2-D
DIGE was analyzed further using the network building tool
Ingenuity Pathway Analysis (Ingenuity Systems, Inc.). The
Ingenuity Pathways Knowledge Base is the largest curated
database of previously published findings on mammalian biology
from the public literature (Ingenuity Systems). The databases
consist of millions of relationships between proteins that are
derived from published data on proteins and small molecules. The
relationships include direct protein interaction, transcriptional
regulation, binding, enzyme-substrate and other structural or
functional relationships. The networks can be visualized graphi-
cally as nodes (proteins) and edges (the relationship between
proteins) alongside empirical expression patterns. The data set
from our study was imported into the IPA systems. Hypothetical
networks of proteins from our experiment and proteins from the
Ingenuity systems database were then built using the de novo
network building algorithm, one of the several algorithms
integrated within Ingenuity systems.
Western blotting
Cell lysates were prepared from HOECs obtained from an
independent set of biological replicates (individuals not used
previously for the initial 2-D DIGE experiment) from healthy
controls and HIV-infected on -HAART or HAART naı ¨ve
subjects. Twenty micrograms of protein extracts from all subjects
was loaded per lane, each lane representing one of the three or
four replicates per experimental group. The proteins were then
resolved by electrophoresis on denatured and reduced 4–12%
polyacrylamide gels (Invitrogen) and transferred onto nitrocellu-
lose membranes for western blotting. The membranes were
blocked with 5% skim milk or 5% BSA for 1 hr at room
temperature with gentle shaking, washed, and incubated overnight
with specific primary antibodies against Pdia1 (0.5 ng/ml), Pdia3
(0.130 ng/ml), Il1nr (0.120 ng/ml), Cstb (0.130 ng/ml), CstA
(0.080 ng/ml), Vim (0.170 ng/ml), Ppp2r1a (1.000 ng/ml), Psmb6
(1.000 ng/ml), total JNKs (0.180 ng/ml) or dual phosphor-JNKs,
(0.150 ng/ml), MEK1/2 (0.017 ng/ml) or phosphor-MEK1/2
(0.066 ng/ml), HSF1 (0.080 ng/ml) and b-actin at (1.000 ng/ml).
The membrane was washed and then incubated for 1 hr at room
temperature with horseradish peroxidase (HRP)-conjugated sec-
ondary antibody (2 ng/ml). After three washes, the blot was
incubated for 5 minutes in chemiluminescent developing sub-
strate, prepared according to the manufacturers’ instructions
(Pierce Biotechnology; Rockford, IL or Cell Signaling Technology;
Danvers, MA). The membrane was removed from the substrates
and placed in plastic sheet protectors and the chemiluminescence
was visualized by exposing the blot to Kodak X-OMAT. The
bands on the films were scanned quantified using ImageQuant-TL
v2005 software (GE Healthcare, Piscataway, NJ). Equal loading of
the protein samples was demonstrated by re-probing the blots for
b-actin (Figure 4 and 5). In data analysis the intensity of each band
was normalized using the b-actin intensity.
Supporting Information
Figure S1 The relationship between power and sample
size at a=0.05 or 0.001 for 50% change in protein
expression. Two datasets from technical replicates and biolog-
ical replicates encompassing technical noise only and both
technical and biological noises respectively were used to estimate
the upper quartile variances and to compute power at various
sample size.
(TIF)
Table S1 Clinical data of the HIV-infected subjects used
for 2-D DIGE and/or validation experiments. The samples
from the first 4 subjects, who are HIV-infected on HAART, were
pooled for the 2-D DIGE analysis. The subject samples 5–11 were
used for the verification analysis. Samples from HIV-infected on
HAART subjects 5, 6,and 7 were presented in the Western blot
analyses of Figure 4. Samples from subjects 8, 9, 10, and 11 were
used for the Western blot analyses presented in Figure 5. Patients 8
and 11 are HAART naı ¨ve while 9 and 10 are on HAART.
1The
mean viral load for subjects 5–11 does not include subjects 8 and
11, who were HAART naı ¨ve.
(DOC)
Table S2 Differential proteome profile of oral epithelial
form HIV-infected on HAART subjects.
(DOC)
Table S3 Database Search Results of spectra acquired
on a Fourier Transform LTQ Mass Spectrometry. The
tandem mass spectra were annotated and generated peak list files
(.DTA), by running SEQUEST extract_msn algorithm in Bio-
works version 3.2 (Thermo Electron, Bremen, Germany). The
resulting peptide mass lists were then used to interrogated
sequences present in an indexed human subset database
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sequences (release 07/04/06) and stored locally, by running
SEQUEST SEARCH algorithm of Bioworks software version 3.2.
SEQUEST searching were performed with maximum peptide and
fragment ion mass tolerance of 2.5 and 1.0 Da respectively, and
with partial methionine oxidation (M)and complete carbamido-
methylation of cysteine (C), and 2 missed cleavage sites were also
allowed in the search parameter. For each protein identification, a
minimum of two peptides with a significant peptide expectation
(P,0.001), peptide Xcorr 1.9, 2.7, and 3.5 for the charge states
and +1, +2, and +3 respectively, minimum Delta CN (Delta
correlation) of 0.1.
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